Global Canine Atopic Dermatitis Market 2024-2028
Canine Atopic Dermatitis Market 2024-2028
The canine atopic dermatitis market is forecasted to grow by USD 231.3 mn during 2023-2028, accelerating at a CAGR of 5.8% during the forecast period. The report on the canine atopic dermatitis market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increase in pet humanization, rising awareness about disease prevention and pet insurance, and rising importance of treatment of allergic conditions in animals.
Technavio's canine atopic dermatitis market is segmented as below:
By Product
- Antihistamines
- Glucocorticoids
- Progestational compounds
- Others
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
This study identifies the increase in merger and acquisition as one of the prime reasons driving the canine atopic dermatitis market growth during the next few years. Also, increasing drug administration in livestock to propel drugs and rising number of veterinary drug stores will lead to sizable demand in the market.
The report on the canine atopic dermatitis market covers the following areas:
- Canine Atopic Dermatitis Market sizing
- Canine Atopic Dermatitis Market forecast
- Canine Atopic Dermatitis Market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading canine atopic dermatitis market vendors that include AB Science SA, Bimeda Holdings Ltd., Bioceltix Spolka Akcyjna, Bioiberica S.A.U., Boehringer Ingelheim International GmbH, Ceva Sante Animale, Dechra Pharmaceuticals Plc, Elanco Animal Health Inc., Merck and Co. Inc., Novartis AG, Toray Industries Inc., Vetoquinol UK Ltd., Vimian Group AB, Virbac Group, and Zoetis Inc.. Also, the canine atopic dermatitis market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.